Biotech | April 08, 2022
Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
Essent continues to broaden its highly characterized, low passage primary cell catalog
Essent continues to broaden its highly characterized, low passage primary cell catalog
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved
The two-day event will showcase achievements and address issues pertaining to the industry
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
